# Use of Glucagon-Like Peptide-1 Medications and Modified Medication Use Among Adults - United States, 2025

Source: [Morbidity and Mortality Weekly Report (MMWR)](https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=766820) · 2026-11-12 · Medicine
Page: https://themorning.science/story/use-of-glucagon-like-peptide-1-medications-and-modified-medication-use-among-adu-1f25b7fd2b28b66a
Kind: research · Impact: medium

## In brief

- A CDC Morbidity and Mortality Weekly Report covers GLP-1 medication use among US adults in 2025.
- The report also covers use of compounded GLP-1 medications.
- The provided sources do not include the report's specific figures.

## Why it matters

It documents how widely GLP-1 drugs, including compounded versions, were used by American adults, giving researchers a population-level baseline.

## Timeline

- 2026-11-12: MMWR report on GLP-1 use among US adults in 2025 published

## Coverage

- [Use of Glucagon-Like Peptide-1 Medications and Modified Medication Use Among Adults - United States, 2025](https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=766820) — Morbidity and Mortality Weekly Report (MMWR), 2026-11-12

Tags: glp-1, public health, medication use, compounded drugs, united states

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science